loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2001_145___rev_04 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Fermion Oy

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    Key Products KEY PRODUCTS

    INTERMEDIATES

    SERVICES

    Key Services KEY SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 FERMION OY Espoo FI (1)

    filter

    01 Methotrexate (1)

    filter

    01 Finland (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    FERMION OY Espoo FI

    Contact Supplier
    • FDA
    • EDQM
    Virtual BoothWith Fermion, start the journey of your innovative API.
    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Methotrexate

    PDF Supplier PDF
    URL Supplier Web Content
    Other DMF EU
    R1-CEP 2001-145 - Rev 04
    Valid
    Chemical
    2018-10-26
    560
    fermion

    CPhI North America

    Booth #1117

    envelop Contact Supplier

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2001-145 - Rev 04 of Fermion Oy Espoo Fi

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2001-145 - Rev 04 of Fermion Oy Espoo Fi 1

    20

    Fermion Oy Espoo Fi, based in Finland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    They are recognized for With Fermion, start the journey of your innovative API.

    One of their significant offerings is Methotrexate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2001-145 - Rev 04

    This Chemical Type CEP, issued on October 26, 2018, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

    Substance Number 560 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY